Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools

Journal of Clinical Microbiology

Volumn 42, Issue 6, 2004, Pages 2470-2475

  Kulmala, S M ^a   Syrjanen S ^a   Shabalova, I ^b,c   Petrovichev, N ^b   Kozachenko, V ^b   Podistov, J ^b   Ivanchenko, O ^d   Zakharenko, S ^e   Nerovjna, R ^f   Kljukina, L ^g   Branovskaja, M ^h   Grunberga, V ⁱ   Juschenko, A ⁱ   Tosi, P ^j   Santopietro, R ^j   Syrjanen K ^k  

^a UNIVERSITY OF TURKU   (Finland)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c Russian Medical Academy of Post Graduate Education   (Russian Federation)

^d Novgorod Clinical Regional Hospital   (Russian Federation)

^e Department of Gynaecology   (Russian Federation)

^f Novgorod Female Consultative O H   (Russian Federation)

^g Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^h BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

ⁱ Latvian Cancer Centre   (Latvia)

^j UNIVERSITY OF SIENA   (Italy)

^k ISTITUTO SUPERIORE DI SANITÀ   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 2942562477     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.6.2470-2475.2004     Document Type: Article

References (29)

1. Clavel, C., M. Masure, J. P. Bory, I. Putaud, C. Mangeonjean, M. Lorenzato, P. Nazeyrollas, R. Gabriel, C. Quereux, and P. Birembaut. 2001. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer 84:1616-1623.
2. Cuzick, J., E. Beverley, L. Ho, G. Terry, H. Sapper, I. Mielzynska, A. Lörincz, W. K. Cnan, T. Krausz, and P. Soutter. 1999. HPV testing in primary screening of older women. Br. J. Cancer 81:554-558.
3. Evander, M., K. Edlund, A. Gustafsson, M. Jonsson, R. Karlsson, E. Rylander, and G. Wadell. 1995. Human papillomavirus infection is transient in young women: population-based cohort study. J. Infect. Dis. 171:1026-1030.
4. Fahey, M. T., L. Irwig, and P. Macaskill. 1995. Meta-analysis of Pap test accuracy. Am. J. Epidemiol. 141:680-689.
5. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
6. Ho, G. Y. F., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-429.
7. Iftner, T., and L. L. Villa. 2003. Human papillomavirus technologies. J. Natl. Cancer Inst. Monogr. 31:80-88.
8. Koutsky, L. A., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
9. Kuhn, L., L. Denny, A. Pollack, A. Lörincz, R. M. Richard, and T. C. Wright. 2000. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J. Nat. Cancer Inst. 92:818-825.
10. Lörincz, A., and J. Anthony. 2001. Advances in HPV detection by hybrid capture. Papillomavirus Rep. 12:145-154.
11. Manos, M. M., W. K. Kinney, L. B. Hurley, M. E. Sherman, S. N. Jen, R. J. Kurman, J. E. Ransley, B. J. Fellerman, J. S. Hartinger, K. M. McIntosh, G. F. Pawlick, and R. A. Hiatt. 1999. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281:1605-1610.
12. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
13. Nanda, K., D. C. McCrory, E. R. Myers, L. A. Bastian, V. Hasselblad, J. D. Hickey, and D. B. Matchar. 2000. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann. Intern. Med. 132:810-819.
14. Peyton, C. L., M. Schiffman, A. T. Lorincz, W. C. Hunt, I. Mielzynska, C. Bratti, S. Eaton, A. Hildesheim, L. A. Morera, A. C. Rodriquez, R. Herrero, M. E. Scherman, and C. M. Wheeler. 1998. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical collection strategies. J. Clin. Microbiol. 36:3248-3254.
15. Ratnam, S., E. L. Franco, and A. Ferenczy. 2000. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol. Biomarkers Prev. 9:945-951.
16. Rietmuller, D., C. Gay, X. Bertrand, D. Bettinger, J. P. Schaal, J. P. Carbillet, C. Lassebe, P. Arveux, E. Seilles, and C. Mougin. 1999. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn. Mol. Pathol. 8:157-164.
17. Rintala, M., P. Pöllänen, V. Nikkanen, S. Grenman, and S. Syrjänen. 2002. Human papillomavirus DNA is found in vas deferens. J. Infect. Dis. 185: 1664-1667.
18. Schiffman, M., R. Derrero, A. Hildesheim, M. E. Sherman, M. Bratti, S. Wacholder, M. Alfaro, M. Hutchinson, J. Morales, M. D. Greenberg, and A. T. Lörincz. 2000. HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica. JAMA 283:87-93.
19. Schneede, P., P. Hillemanns, F. Ziller, A. Hofstetter, E. Stockfleth, R. Arndt, and T. Meyer. 2001. Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening. Acta Obstet. Gynecol. Scand. 80:750-762.
20. Syrjänen, K., and S. Syrjänen. 2000. Papillomavirus infections in human pathology. John Wiley & Sons, Inc., New York, N.Y.
21. Syrjänen, S., I. P. Shabalova, N. Petrovichev, V. P. Kozachenko, T. Zacharova, A. Pajanidi, J. I. Podistov, G. Chemeris, L. G. Sozaeva, E. V. Lipova, I. Tsidaeva, O. Ivanchenko, G. Pshepurko, S. Zakharenko, R. Nerovjna, L. B. Kljukina, O. A. Erokhina, M. F. Branovskaja, M. Nikitina, V. Grunberga, A. Grunberg, A. Juschenko, B. Johansson, P. Tosi, M. Cintorino, R. Santopietro, and K. J. Syrjänen. 2003. Sexual habits and human papillomavirus (HPV) infections among women in three New Independent States of the former Soviet Union. Sex. Transm. Dis. 30:680-684.
22. Syrjänen, S., I. P. Shabalova, N. Petrovichev, V. P. Kozachenko, T. Zacharova, A. Pajanidi, J. I. Podistov, G. Chemeris, L. G. Sozaeva, E. V. Lipova, I. Tsidaeva, O. Ivanchenko, G. Pshepurko, S. Zakharenko, R. Nerovjna, L. B. Kljukina, O. A. Erokhina, M. F. Branovskaja, M. Nikitina, V. Grunberga, A. Grunberg, A. Juschenko, P. Tosi, M. Cintorino, R. Santopietro, and K. J. Syrjänen. 2004. Acquisition of incident high-risk human papillomavirus (HPV) infections and Pap smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union. J. Clin. Microbiol. 42:505-511.
23. Syrjänen, S., I. P. Shabalova, N. Petrovichev, V. P. Kozachenko, T. V. Zacharova, J. Pajanidi, J. I. Podistov, G. Chemeris, L. G. Sozaeva, E. V. Lipova, I. Tsidaeva, O. G. Ivanchenko, A. A. Pshepurko, S. Zakharenko, R. Nerovjna, L. P. Kljukina, O. A. Erokhina, M. F. Branovskaja, M. Nikitina, V. Grunberga, A. Grunberg, A. Juschenko, P. Tosi, M. Cintorino, R. Santopietro, and K. J. Syrjänen. 2002. Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former Soviet Union. J. Lower Genital Tract Dis. 6:97-110.
24. Terry, G., L. Ho, P. Londesborough, J. Cuzick, I. Mielzynska-Lohnas, and A. Lörincz. 2001. Detection of high-risk HPV types by the Hybrid Capture 2 test. J. Med. Virol. 65:155-162.
25. van den Brule, A. J., P. J. Snijders, R. L. Gordijn, O. P. Bleker, C. J. Meijer, and J. M. Walboomers. 1990. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int. J. Cancer 45:644-649.
26. Venturoli, S., M. Cricca, F. Bonvicini, F. Giosa, F. R. Pulvirenti, C. Galli, M. Musiani, and M. Zerbini. 2002. Human papillomavirus DNA testing by PCR-ELISA and Hybrid Capture II from a single cytological specimen: concordance and correlation with cytological results. J. Clin. Virol. 25:177-185.
27. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
28. Yamazaki, H., T. Sasagawa, W. Basha, T. Segawa, and M. Inoue. 2001. Hybrid Capture-II and LCR-E7 assays for HPV typing in cervical cytologic samples. Int. J. Cancer 94:222-227.
29. zur Hausen, H. 2000. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.